[ALNY] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -49.96%
YoY- -99.52%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 187,633 125,853 70,061 2,069 17,096 13,651 6,324 75.85%
PBT -204,236 -252,452 -208,929 -244,837 -122,937 -104,071 -76,792 17.68%
Tax 278 839 -394 445 -3,296 -2,204 -1,610 -
NP -204,514 -253,291 -208,535 -245,282 -122,937 -104,071 -76,792 17.71%
Tax Rate - - - - - - - -
Total Cost 392,147 379,144 278,596 247,351 140,033 117,722 83,116 29.47%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -109.00 -201.26 -297.65 -11,855.10 -719.10 -762.37 -1,214.29 -33.06%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.72 -2.18 -1.92 -2.43 -1.34 -1.21 -0.91 11.18%
EPS Diluted -1.72 -2.18 -1.92 -2.43 -1.34 -1.21 -0.91 11.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.